Ir a las Transacciones
Salud

PanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production

PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Additional equity and debt funding brings the total amount raised to US$150 million (€134 million). In addition to EQT Life Sciences, the Series A round was also joined by Kurma Partners, Eurazeo, Korys, Paladin and PMV.

PanTera, an IBA and SCK CEN joint venture, aims to secure the large-scale production of actinium-225 (225Ac), which is one of the most promising alpha-emitting radioisotopes to fight cancer. The funds raised will be used primarily toward the construction of a state-of-the-art production facility in Belgium. This facility will not only enable large-scale production, it will also help fulfill PanTera’s ultimate goal to improve the accessibility of future, innovative cancer therapy based on 225Ac and theranostics.

Oaklins’ team in Belgium acted as the sole financial advisor in this transaction.

Contáctese con el equipo de la transacción

Cédric Michils

Director Ejecutivo
Bruselas, Bélgica
Oaklins KBC Securities

Bart Delusinne

Director Ejecutivo
Bruselas, Bélgica
Oaklins KBC Securities

Nicolas Lambers

Asociado Director
Bruselas, Bélgica
Oaklins KBC Securities

Michaël Rixhon

Asociado Director
Bruselas, Bélgica
Oaklins KBC Securities

Nicholas Matthyssens

Asociado Senior
Bruselas, Bélgica
Oaklins KBC Securities

Robin Bundervoet

Asociado
Bruselas, Bélgica
Oaklins KBC Securities

Niels Maes

Asociado
Bruselas, Bélgica
Oaklins KBC Securities

Transacciones relacionadas

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
Salud

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth, as well as investing in service quality, innovation and efficiency.

Conozca más
HD Clinical Ltd. has been acquired by NEXUS AG
Salud | TMT

HD Clinical Ltd. has been acquired by NEXUS AG

NEXUS AG has acquired HD Clinical Ltd. Through this acquisition, NEXUS has gained a recognized and internationally active team of experts in structured diagnostic reporting and image processing. This will provide new regional access, strengthening its strong European market position in software, particularly for internal medicine.

Conozca más
Reed Veterinary Surgery has been acquired by Kin Vet Community
Private Equity | Salud

Reed Veterinary Surgery has been acquired by Kin Vet Community

The acquisition of Reed Veterinary Surgery by Kin Vet Community has been successfully completed. Through this acquisition, the surgery joins a community of veterinary clinics where colleagues share knowledge and best practices to improve the wellbeing of their clients and their animals.

Conozca más